Collagen Vascular Disease- A Review
Mrs Shailaja K S1 , Mrs Purohit Saraswati2
1Asst Lecturer, J.S.S College of Nursing, Mysuru
2Asst Lecturer, J.S.S College of Nursing, Ramanuja Road. Mysuru-570004
*Corresponding Author’s Email: shylanju212@gmail.com,
saruswati28@gmail.com
ABSTRACT:
Collagen vascular disease
occurs when problems with the immune system affect collagen. Collagen is a
tough, fiber-like protein that makes up about a third of body protein. It is
part of the structure of tendons, bones, and connective tissues. In a
class of diseases known as autoimmune
disorders, the body's immune system attacks its own tissues. Some of
these diseases are similar to each other such as arthritis and inflammation of
arteries in the tissues that connect joints and other tissues. As a group,
these diseases are known as collagen vascular diseases.
KEYWORDS: Collagen,
Auto immune, Scleroderma, Arthritis, immune system.
INTRODUCTION:
Collagen vascular disease
refers to a group of diseases that affect your connective tissue. Collagen is a
protein-based connective tissue that forms a support system for your skin. The
connective tissue holds bones, ligaments, and muscles together. Collagen
vascular disease is sometimes also called connective tissue disease.
Some disorders classified
as collagen vascular diseases affect your joints, skin, blood vessels, or other
vital organs. Symptoms vary according to the specific disease. The classic collagen vascular diseases have a "classic"
presentation with typical findings that doctors can recognize during an
examination. Each also has "classic" blood test abnormalities and abnormal
antibody patterns. However, each of these diseases can evolve slowly or rapidly
from very subtle abnormalities before demonstrating the classic features that
help in the diagnosis. The classic collagen vascular diseases include:
·
Systemic lupus erythematosus
(SLE)– An inflammation of the connective tissues, SLE can afflict every organ
system. It is up to nine times more common in women than men and strikes black
women three times as often as white women. The condition is aggravated by
sunlight.
·
Rheumatoid arthritis – Rheumatoid
arthritis is a systemic disorder in which immune cells attack and inflame the
membrane around joints. It also can affect the heart, lungs, and eyes. Of the
estimated 2.1 million Americans with rheumatoid arthritis, approximately 1.5
million (71 percent) are women.
·
Scleroderma
– an activation of immune cells that produces scar tissue in the skin, internal
organs, and small blood vessels. It affects women three times more often than
men overall, but increases to a rate 15 times greater for women during
childbearing years, and appears to be more common among black women.
·
Sjögren's syndrome –
also called Sjögren's disease, is a chronic, slowly
progressing inability to secrete saliva and tears. It can occur alone or with
rheumatoid arthritis, scleroderma, or systemic lupus erythematosus.
Nine out of 10 cases occur in women, most often at or around mid-life.
· Mixed connective tissue disease – Mixed connective-tissue disease (MCTD) is a disorder in which features of various connective-tissue diseases (CTDs) such as systemic lupus erythematosus (SLE); systemic sclerosis (SSc);dermatomyositis
(DM); polymyositis (PM); anti-synthetase syndrome; and, occasionally, Sjögren syndrome can coexist and overlap. The course of the disease is chronic and usually milder than other CTDs. In most cases, MCTD is considered an intermediate stage of a disease that eventually becomes either SLE or Scleroderma.·
Psoriatic arthritis is also a collagen vascular
disease.
Collagen vascular disease
is an autoimmune disease. This means that your immune system mistakenly attacks
your body’s healthy tissue. The attacks are usually in the form of
inflammation. In this case, your immune system causes inflammation in the
collagen and nearby joints. According to the National Institutes of Health, the
cause of the attacks is not known (NIH, 2011). Several collagen vascular
diseases, including lupus, scleroderma, and rheumatoid arthritis, are more
common in women than men. This group of diseases usually affects adults in
their 30s and 40s. According to the Mayo Clinic, children as young as 15 can be
diagnosed with lupus (Mayo Clinic,
2011).
Symptoms of
Collagen Vascular Disease:
Each type of collagen
vascular disease has its own set of symptoms. However, most forms of collagen
vascular disease do share some of the same general symptoms (NIH, 2011).
People with collagen vascular disorders typically experience:
·
fatigue
·
muscle
weakness
·
fever
·
body
aches
·
joint
pain
·
skin
rash
Lupus is a collagen
vascular disease that causes unique symptoms in each patient. Additional
symptoms can include shortness of breath, chest pain, headaches, and dry eyes.
People with lupus may have long periods of remission without symptoms. Symptoms
can flare up during times of stress or after prolonged exposure to sunlight.
Rheumatoid arthritis
affects about 1.3 million adults in the United States, according to the
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS,
2009). Inflammation of the connective tissue between the joints causes pain and
stiffness. Some patients have chronic problems with dry eyes and a dry mouth.
Some people with this form of collagen vascular disease also have an
inflammation of the blood vessels or of the heart’s lining.
Scleroderma is an
autoimmune disease that can affect the skin or other organs, including the
heart, lungs, or digestive tract. Symptoms include thickening and hardening of
the skin, rashes, or open sores. Your skin may feel tight as if it is being
stretched, or feel lumpy in areas. Systemic scleroderma can cause coughing,
wheezing, and breathing difficulties. Diarrhea, acid reflux, joint pain, or
numbness in the feet are also possible symptoms.
Temporal arteritis is another form of collagen vascular disease.
People with temporal arteritis have an inflammation
of the large artery in the head. Symptoms are most common in adults over the
age of 70, according to the Southern California College of Optometry (SCCO).
Symptoms can include scalp sensitivity, jaw pain, headaches, and vision loss.
Treatment for collagen
vascular disease varies according to your individual condition. However,
corticosteroid and immunosuppressant medications commonly treat many connective
tissue diseases.
Corticosteroids reduce
inflammation throughout the body. This class of drugs also helps normalize your
immune system. Corticosteroids can carry major side effects in some people,
including weight gain and mood changes. Some people may see a rise in blood
sugar while taking corticosteroid medications.
Immunosuppressant
medication works by lowering your immune response. When your immune response is
lower, your body will no longer attack itself as much. However, having a
lowered immunity can increase your risk of becoming sick at times. Protect
yourself from simple viruses by staying away from family and friends with colds
or flu.
Physical therapy or gentle
exercise can also treat collagen vascular disease. Range of motion exercises
help you retain your mobility and may reduce joint and muscle pain.
The outlook for collagen
vascular disease varies in each person, and really depends on the specific
disease. However, they do have one thing in common: all autoimmune diseases are
chronic conditions. They have no cure, and you must manage them throughout your
life. Luckily, there are effective treatments to help keep even severe symptoms
at bay.
REFERENCES:
1. Collagen vascular disease [cited 2015 August
26] Available from: http://www.healthline.com/health/collagen-vascular-disease Erica Roth | Published on August 28, 2012
2. William C. Shiel
Jr., Connective
Tissue Disease; [cited 2015 August 26] Available from
http://www.medicinenet.com/connective_tissue_disease/article.htm
3. Medline Plus,
Collagen vascular disease. [cited 2015 August 31]Available from
https://www.nlm.nih.gov/medlineplus/ency/article/001223.htm
Received on 31.08.2015 Modified on 21.09.2015
Accepted on 24.09.2015 © A&V Publication all right reserved
Int. J. Adv. Nur. Management 3(4): Oct. - Dec. 2015; Page 382-384
DOI: 10.5958/2454-2652.2015.00040.2